Source Natural Foods & Herbal Suppl Ltd

BSE: SOURCENTRL531398ISIN INE679C01027

Healthcare
Pharmaceuticals

Share price

₹109.80+2.75 (+2.57%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹155.90
52W low: ₹96.55
Off 52W high: -29.57%
1M return: -4.52%
3M return: +1.95%
6M return: -14.25%
1Y return: -23.56%
20D avg volume: 1,328
50 DMA: ₹109.94
200 DMA: ₹117.32

Key ratios Consolidated

Market cap: ₹70.68 Cr
Current price: ₹109.80
52W high / low: ₹155.90 / ₹96.55
Face value: ₹10.00
P/E: 0.00
P/B: —
EPS (TTM): ₹0.00
Book value / share: —
ROE: —
ROCE: —
Operating margin: —
Net margin: —
Debt / equity: —
Net debt: —
Interest cover: —
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: —

Financials

Metric	Q1 FY27
Income statement
	21.35
	0.18
	21.53
	20.61
	2.30
	14.88
	1.23
	0.28
	0.10
	1.42
	0.92
	0.00
	0.92
	0.24
	0.68
	1.06
Key metrics
	1.30
	6.10%
	3.20%

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	21.42	21.03	20.30	16.95	12.10	16.07	10.45	10.26	8.16	—
	0.18	0.04	0.01	0.00	0.01	0.06	0.01	—	0.01	—
	21.61	21.07	20.30	16.95	12.11	16.12	10.45	10.26	8.17	—
	20.61	19.06	19.19	16.01	11.26	15.26	9.24	9.32	7.60	—
	2.30	1.60	2.50	2.14	1.78	3.19	1.41	1.14	1.04	—
	14.88	15.51	13.31	11.40	7.14	10.60	5.62	6.46	5.11	—
	1.23	1.30	1.08	1.06	1.04	0.85	0.93	0.74	0.75	—
	0.28	0.17	0.15	0.16	0.16	0.17	0.20	0.18	0.08	—
	0.10	0.10	0.26	0.26	0.25	0.25	0.25	0.26	0.26	—
	1.42	1.52	1.07	0.90	0.82	0.77	0.78	0.80	0.69	—
	1.00	2.01	1.11	0.95	0.85	0.86	1.22	0.94	0.57	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	1.00	2.01	1.11	0.95	0.85	0.86	1.22	0.94	0.57	—
	0.26	0.52	0.29	0.25	0.22	0.24	0.20	0.10	0.15	—
	0.74	1.49	0.82	0.70	0.63	0.63	1.02	0.84	0.42	—
	1.15	2.29	1.28	1.09	0.98	0.97	1.58	1.30	0.65	—
Key metrics
	1.38	2.28	1.52	1.37	1.26	1.28	1.67	1.38	0.91	—
	6.40%	10.80%	7.50%	8.10%	10.40%	8.00%	16.00%	13.50%	11.20%	—
	3.50%	7.10%	4.00%	4.10%	5.20%	3.90%	9.80%	8.20%	5.10%	—
	—	8.30%	—	4.60%	—	4.50%	—	—	—	—
	77.00%	30.90%	94.30%	65.20%	48.30%	—	—	—	—	—
	17.50%	136.50%	-19.60%	-16.70%	50.00%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	79.70	70.38	44.92	—
	0.23	0.06	0.08	—
	79.93	70.43	45.00	—
	74.87	65.51	41.42	—
	8.54	8.02	6.77	—
	55.10	47.36	27.79	—
	4.67	4.47	3.27	—
	0.76	0.65	0.62	—
	0.72	0.38	1.02	—
	4.91	4.80	3.04	—
	5.07	4.92	3.58	—
	0.00	0.00	0.00	—
	5.07	4.92	3.58	—
	1.32	1.28	0.68	—
	3.75	3.65	2.90	—
	5.81	5.64	4.51	—
Key metrics
	6.55	5.95	5.22	—
	8.22%	8.50%	11.60%	—
	4.71%	5.20%	6.50%	—
	—	21.10%	18.30%	—
	63.05%	56.70%	—	—
	20.19%	25.90%	—	—
	—	-3.10	-0.02	—
	—	-0.68	0.02	—
	—	0.30	0.33	—
	—	5.58	0.18	—
	—	108.4	134.4	—
Balance sheet
	—	40.93	37.33	—
	—	31.67	27.67	—
	—	2.21	7.23	—
	—	17.87	13.74	—
	—	8.46	6.07	—
	—	—	0.00	—
	—	4.16	3.93	—
	—	5.43	3.26	—
	—	14.51	14.41	—
	—	7.79	7.41	—
	—	7.79	7.41	—
	—	0.00	0.00	—
	—	25.76	22.36	—
Cash flow
	—	-2.49	0.07	—
	—	-2.36	-5.33	—
	—	-0.17	5.40	—
	—	0.61	0.09	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +63.05%
Profit YoY (TTM): +20.19%

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 74.37%

Quarter	September 2026	June 2026
Promoter %	74.37%	74.37%

Holder	Type	Holding	Previous	Change
SRIVEDA SATTVA PRIVATE LIMITED	Promoter	74.37%	74.37%	0.00%
GUTTIKONDA VARA LAKSHMI	Public	2.96%	2.96%	0.00%
PUSHPALATHA AGARWAL	Public	1.82%	—	—
MULTIPLEX CAPITAL LIMITED	Public	1.31%	1.13%	+0.18%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
Source Natural Foods & Herbal Suppl Ltd S	71	109.80	18.80	21.10%	+63.05% TTM	+20.19% TTM	-23.56%

Filings & corporate actions

Recent announcements

Certificate under Regulation 74(5) of SEBI (DP) Regulations, 201814 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We wish to inform you that the Members at the 31st AGM of the company held on September 30, 2026 approved the appointment of M/s. K.B. Nambiar & Associates, Chartered Accountants, as the ....1 Oct 2026 · Company Update / Appointment of Statutory Auditor/s
Consolidated Scrutinizer''s report for the e-voting conducted for the 31st AGM of the Company.1 Oct 2026 · AGM/EGM / AGM
Closure of Trading Window for the quarter and half year ending September 30, 202630 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Proceedings of 31st Annual General Meeting held on September 30, 202630 Sep 2026 · AGM/EGM / AGM
Announcement under Regulation 30 (LODR) Regulations, 2015 - Receipt of Ayush Quality Mark Certification23 Sep 2026 · Company Update / General
Newspaper Publication for the 31st Annual General Meeting of the Company10 Sep 2026 · Company Update / Newspaper Publication
Intimation of Book Closure and Record date for the purpose of 31st Annual General Meeting of the Company8 Sep 2026 · Corp Action / Dividend/AGM
Notice of 31st Annual General Meeting8 Sep 2026 · Company Update / General
Notice of 31st AGM and Annual report for the financial year 2025-26.8 Sep 2026 · Others / Reg. 34 (1) Annual Report
Appointment of Statutory Auditors from the conclusion of ensuing 31st Annual general Meeting, subject to approval of the members.3 Sep 2026 · Company Update / Appointment of Statutory Auditor/s
Appointment of Chief Financial officer3 Sep 2026 · Company Update / Change in Management
Outcome of Board Meeting for Appointment of Statutory Auditors and Chief Financial Officer.3 Sep 2026 · Others / Outcome without intimation
Approval for incorporation of a Wholly Owned Subsidiary Company under the name "SN Solar Mangaluru Private Limited''''31 Aug 2026 · Company Update / General
Newspaper Publication - Unaudited Financial results for the quarter ended June 30, 202612 Aug 2026 · Company Update / Newspaper Publication
Proposed Incorporation of Wholly Owned Subsidiary12 Aug 2026 · Company Update / General
Financial results for the quarter ended June 30, 202610 Aug 2026 · Result / Financial Results
Outcome of Board meeting for the quarter ended June 30, 2026.10 Aug 2026 · Board Meeting / Outcome of Board Meeting
Source Natural Foods And Herbal Supplements Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve ....5 Aug 2026 · Board Meeting / Board Meeting
Certificate in terms of regulation 74(5) of SEBI (Depositories and Participants) Regulations, 201810 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of Trading window for the quarter ended June 30, 202630 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Approval for incorporation of a Wholly Owned Subsidiary Company under the name "Source Natural Estates Private Limited"19 Jun 2026 · Company Update / General
Newspaper Publication for the Audited Financial Results for the quarter and year ended March 31, 202630 May 2026 · Company Update / Newspaper Publication
Re-appointment of Cost Auditor and Internal Auditor of the Company for the Financial year 2026-2728 May 2026 · Company Update / General
Announcement under Regulation 30 (LODR), 2015 - Resignation of Chief Financial Officer28 May 2026 · Company Update / Resignation of Chief Financial Officer (CFO)
Audited Financial Results for the quarter and year ended March 31, 202628 May 2026 · Result / Financial Results
Outcome of Board Meeting - Audited Financial Results of the Company for the quarter and year ended March 31, 202628 May 2026 · Board Meeting / Outcome of Board Meeting
Source Natural Foods And Herbal Supplements Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve ....24 May 2026 · Board Meeting / Board Meeting
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''> <tr> <td>Sr. No.</td> <td>Particulars</td> ....27 Apr 2026 · Others / Format of the Annual Disclosure to be made by an entity identified as a LC : Annexure B2
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 20189 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of Trading Window31 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
Outcome of Board Meeting6 Mar 2026 · Others / Outcome without intimation
Newspaper Publication for Unaudited Financial Results for the quarter and nine months ended December 31, 2025.16 Feb 2026 · Company Update / Newspaper Publication
Unaudited Financial Results for the quarter and nine months ended December 31, 202514 Feb 2026 · Board Meeting / Outcome of Board Meeting
Unaudited Financial Results for the quarter and nine months ended December 31, 202514 Feb 2026 · Result / Financial Results
Incorporation of Wholly Owned Subsidiary Company.11 Feb 2026 · Company Update / General
Source Natural Foods And Herbal Supplements Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve ....9 Feb 2026 · Board Meeting / Board Meeting
Outcome of Board Meeting - Proposed Incorporation of a Wholly-owned Subsidiary12 Jan 2026 · Company Update / General
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended December 31, 20259 Jan 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of Trading window for the quarter and nine months ended December 31, 2025.31 Dec 2025 · Insider Trading / SAST / Closure of Trading Window

Board meetings

10 Aug 2026 Board Meeting - Financial Results